Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tongluo Yanggan is a traditional Chinese medicine (TCM) formulation used as an external application, often in combination with other TCM decoctions, for the treatment of liver-related diseases such as autoimmune hepatitis and hepatitis B-related liver fibrosis. The formula is applied topically and is believed to act by promoting blood circulation ("tong luo" means "unblock the collaterals") and nourishing or supporting ("yang") the liver ("gan"). Its mechanism of action is rooted in TCM theory rather than modern pharmacology, focusing on improving symptoms associated with liver dysfunction. There are ongoing clinical studies investigating its efficacy for autoimmune hepatitis and hepatitis B-related liver fibrosis[1][3]. The specific herbal composition, molecular targets, or active ingredients have not been detailed in available sources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tongluo Yanggan.